Yes, there are a number of collaborations with various research groups around the world. For example, with regard to immunization, there is currently a collaboration with a Boston group with a view to humanizing the antibodies identified. Antibodies have been developed in mice. Going directly to clinical trials with patients would be a bad idea because they would develop rather adverse immune reactions. Thus, we have to humanize these antibodies. Some groups in the United States have specialized in this technology. We are actively working with them to carry out this research. There are also other proteins involved, not just the SOD1 protein I mentioned. Other genetic mutations have been identified, other abnormal proteins have been found in ALS patients. A great deal of research is currently being conducted on this subject.
On November 2nd, 2010. See this statement in context.